BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22047447)

  • 1. Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex.
    Zhan X; Kaoud TS; Dalby KN; Gurevich VV
    Biochemistry; 2011 Dec; 50(48):10520-9. PubMed ID: 22047447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-activated protein (MAP) kinase kinases.
    Zhan X; Kaoud TS; Kook S; Dalby KN; Gurevich VV
    J Biol Chem; 2013 Oct; 288(40):28535-47. PubMed ID: 23960075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
    Perry-Hauser NA; Kaoud TS; Stoy H; Zhan X; Chen Q; Dalby KN; Iverson TM; Gurevich VV; Gurevich EV
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
    Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
    J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.
    Zhan X; Perez A; Gimenez LE; Vishnivetskiy SA; Gurevich VV
    Cell Signal; 2014 Apr; 26(4):766-76. PubMed ID: 24412749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
    Guo C; Whitmarsh AJ
    J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
    Willoughby EA; Collins MK
    J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does arrestin assemble MAPKs into a signaling complex?
    Song X; Coffa S; Fu H; Gurevich VV
    J Biol Chem; 2009 Jan; 284(1):685-695. PubMed ID: 19001375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrestin-dependent activation of JNK family kinases.
    Zhan X; Kook S; Gurevich EV; Gurevich VV
    Handb Exp Pharmacol; 2014; 219():259-80. PubMed ID: 24292834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.
    Li X; MacLeod R; Dunlop AJ; Edwards HV; Advant N; Gibson LC; Devine NM; Brown KM; Adams DR; Houslay MD; Baillie GS
    FEBS Lett; 2009 Oct; 583(20):3310-6. PubMed ID: 19782076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.
    Breitman M; Kook S; Gimenez LE; Lizama BN; Palazzo MC; Gurevich EV; Gurevich VV
    J Biol Chem; 2012 Jun; 287(23):19653-64. PubMed ID: 22523077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
    Seo J; Tsakem EL; Breitman M; Gurevich VV
    J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrestin-3 scaffolding of the JNK3 cascade suggests a mechanism for signal amplification.
    Perry NA; Kaoud TS; Ortega OO; Kaya AI; Marcus DJ; Pleinis JM; Berndt S; Chen Q; Zhan X; Dalby KN; Lopez CF; Iverson TM; Gurevich VV
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):810-815. PubMed ID: 30591558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade.
    Qu C; Park JY; Yun MW; He QT; Yang F; Kim K; Ham D; Li RR; Iverson TM; Gurevich VV; Sun JP; Chung KY
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
    Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs).
    Zhan X; Kaoud TS; Dalby KN; Gurevich EV; Gurevich VV
    Curr Protoc; 2023 Sep; 3(9):e839. PubMed ID: 37668419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
    Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
    PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffolding of Mitogen-Activated Protein Kinase Signaling by β-Arrestins.
    Kim K; Han Y; Duan L; Chung KY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.
    Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ
    J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.